SESSION 25: LOWER EXTREMITY TOPICS RELATED TO BTK LESION DCBS AND STENTING – STANDARD AND NEW BIORESORBABLE
Location: Grand Ballroom East, 3rd Floor
Moderators: Michael S. Conte, MD / Sahil A. Parikh, MD / Kenneth Ouriel, MD, MBA
Moderators: Michael S. Conte, MD / Sahil A. Parikh, MD / Kenneth Ouriel, MD, MBA
8:53 AM - 8:58 AM
Experience To Date With Everolimus And Other Nonabsorbable Coronary DESs To Treat Infrapopliteal BTK Lesions – Long And Short – Causing CLTI: What Are The Stents And When Do They Help: Might The Drug Eluting Resorbable Stents (DRSs) Be Better
Presenter(s): Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
8:59 AM - 9:04 AM
3-Year Results Of The Esprit (Abbott) Drug Eluting Resorbable Stent (DRS) In The LIFE-BTK RCT Comparing It With Plain Old Balloon Angioplasty (POBA): DRSs Make A Difference
Presenter(s): Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:05 AM - 9:10 AM
2-Year Results Of The Magnitude Sirolimus Eluting Bioresorbable Stent (From R3 Vascular): For BTK Lesions: How Does It Compare With Other Treatments: Is Intravascular Lithotripsy (IVL-Shockwave) Feasible To Treat BTK Lesions
Presenter(s): Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:11 AM - 9:16 AM
Bioresorbable Magnesium Scaffold (Stent — BIOTRONIK) Has Been Improved For Lower Extremity And Coronary Lesions: Current Status, Advantages And Limitations
Presenter(s): Ron Waksman, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:17 AM - 9:22 AM
Update On The Value Of DCBs For BTK Angioplasty Including RCT Comparisons Of A Sirolimus DCB (Magic Touch – Concept Medical) And A Paclitaxel DCB (Lithos – Acotec) vs. POBA
Presenter(s): Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:23 AM - 9:28 AM
With The Good Results Of The DRSs: After Their Approval What Unmet Needs In The Treatment Of BTK Disease Remain To Be Met
Presenter(s): Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:29 AM - 9:34 AM
Promising Results To Date With Bioresorbable DESs To Treat BTK Lesions: How Will They Change The Open/Endo Balance For Treating CLTI: The Need For Open Bypasses Will Be Diminished But Will Never Fade Away
Presenter(s): Steven Kum, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:35 AM - 9:40 AM
How Does The LIFE BTK Study With Esprit Bioresorbable DRS (From Abbott) Change The BEST-CLI Conclusions For BTK Lesions
Presenter(s): Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:41 AM - 9:46 AM
Other BTK Resorbable Stent Platforms Including A Sirolimus Coated One From R3 Vascular: What Will Be The Impact Of BTK DRSs And How Will Vessel Prep Differ With BTK Bioresorbable Stent Platforms
Presenter(s): Sahil A. Parikh, MD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:47 AM - 9:52 AM
The Value Of Everolimus Eluting Coronary Stents (Xience — Abbott) Bailout Stenting Of BTK Lesions After Angioplasty Causing CLTI: From A Real-World Multicenter Study
Presenter(s): Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
View Slides in PDF
9:53 AM - 9:59 AM
Panel Discussion
Location: Grand Ballroom East, 3rd Floor 10:00 AM - 10:12 AM
Break — Visit Exhibits And Pavilions (2nd and 3rd Floors)